Back to Search Start Over

445TiP VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
09237534
Volume :
33
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........48bdf59fbb79f74dce5284ea9c2d3adc
Full Text :
https://doi.org/10.1016/j.annonc.2022.07.1866